Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.58
-0.23 (-2.13%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 278.73 | 232.19 | 222.95 | 241.58 | 848.63 | 347.82 |
Short-Term Investments | 254 | 234.83 | 682.4 | 1,281 | 1,553 | 360.33 |
Cash & Short-Term Investments | 532.73 | 467.02 | 905.35 | 1,522 | 2,402 | 708.15 |
Cash Growth | -12.09% | -48.42% | -40.53% | -36.62% | 239.20% | -3.90% |
Accounts Receivable | - | - | - | - | - | 773.08 |
Other Receivables | 5.6 | 3.6 | 5 | 11.6 | 28.9 | - |
Receivables | 5.6 | 3.6 | 5 | 11.6 | 28.9 | 773.08 |
Prepaid Expenses | 33.48 | 41.54 | 42.73 | 40.95 | 57.84 | 73 |
Restricted Cash | 1.93 | 1.92 | 89.39 | 13.27 | 12.68 | 8.59 |
Other Current Assets | - | - | - | - | 17.62 | - |
Total Current Assets | 573.74 | 514.08 | 1,042 | 1,588 | 2,519 | 1,563 |
Property, Plant & Equipment | 109.82 | 117.72 | 122.86 | 167.2 | 188.17 | 130.05 |
Long-Term Investments | 475.02 | 314.58 | 190.02 | 105.28 | 23.93 | 201.39 |
Goodwill | 16.94 | 16.94 | 16.94 | 16.94 | 16.94 | 16.94 |
Other Intangible Assets | 7.7 | 7.85 | 8.12 | 22.57 | 32.76 | 33.29 |
Other Long-Term Assets | 31.59 | 31.66 | 18.42 | 18.86 | 21.23 | 9.78 |
Total Assets | 1,215 | 1,003 | 1,399 | 1,919 | 2,802 | 1,954 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 17.75 | 9.8 | 5.08 | 6.33 | 6.42 | 6.52 |
Accrued Expenses | 66.24 | 72.39 | 66.53 | 82.15 | 462.07 | 129.54 |
Current Portion of Leases | 9.14 | 8.8 | 7.75 | 12.87 | 4.14 | 3.93 |
Current Income Taxes Payable | - | - | - | - | 15.23 | 6.22 |
Current Unearned Revenue | - | - | 12.65 | 64.85 | 15.52 | 98.21 |
Other Current Liabilities | 1.83 | 1.83 | 27.65 | 9.2 | 7.65 | 96.83 |
Total Current Liabilities | 94.96 | 92.82 | 119.66 | 175.41 | 511.03 | 341.24 |
Long-Term Leases | 84.14 | 89.05 | 90.14 | 111.67 | 123.84 | 133.56 |
Long-Term Unearned Revenue | - | - | - | - | 53.21 | 3.82 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 18.44 |
Other Long-Term Liabilities | 53.22 | 55.68 | 38.63 | 41.74 | 36.05 | 25.36 |
Total Liabilities | 232.31 | 237.55 | 248.43 | 328.82 | 724.13 | 522.42 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 2,230 | 1,965 | 1,912 | 1,829 | 1,710 | 1,572 |
Retained Earnings | -1,243 | -1,198 | -759.78 | -237.82 | 377.24 | -138.6 |
Comprehensive Income & Other | -4.6 | -2.06 | -1.72 | -0.82 | -9.12 | -1.1 |
Total Common Equity | 982.49 | 765.28 | 1,150 | 1,590 | 2,078 | 1,432 |
Shareholders' Equity | 982.49 | 765.28 | 1,150 | 1,590 | 2,078 | 1,432 |
Total Liabilities & Equity | 1,215 | 1,003 | 1,399 | 1,919 | 2,802 | 1,954 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 93.27 | 97.85 | 97.89 | 124.54 | 127.97 | 137.49 |
Net Cash (Debt) | 439.45 | 369.16 | 807.46 | 1,398 | 2,274 | 570.66 |
Net Cash Growth | -12.77% | -54.28% | -42.24% | -38.53% | 298.50% | -14.40% |
Net Cash Per Share | 2.96 | 2.67 | 5.93 | 10.42 | 16.87 | 4.28 |
Filing Date Shares Outstanding | 169.22 | 139.52 | 137.14 | 135.03 | 133.53 | 132.3 |
Total Common Shares Outstanding | 169.19 | 139.47 | 136.96 | 134.78 | 133.24 | 131.16 |
Working Capital | 478.78 | 421.27 | 922.8 | 1,413 | 2,008 | 1,222 |
Book Value Per Share | 5.81 | 5.49 | 8.40 | 11.80 | 15.60 | 10.92 |
Tangible Book Value | 957.85 | 740.49 | 1,125 | 1,551 | 2,028 | 1,382 |
Tangible Book Value Per Share | 5.66 | 5.31 | 8.22 | 11.51 | 15.22 | 10.53 |
Machinery | 46.8 | 46.49 | 44.9 | 49.4 | 41.93 | 22.57 |
Construction In Progress | - | 0.11 | 1.07 | 0.23 | - | 26.93 |
Leasehold Improvements | 56.26 | 56.18 | 53.99 | 80.29 | 84.42 | 7.83 |